| HCAT |
Health Catalyst, Inc. |
Common Stock, $0.01 par value |
17.18% |
$48.1M |
$19.3M |
12M |
+67.3% |
Mathew P. Arens |
May 7, 2025 |
| PHLT |
Performant Healthcare, Inc. |
Common Stock, $0.01 par value |
16.36% |
$98.2M |
|
12.9M |
|
Mathew P. Arens |
Jun 30, 2025 |
| AXGN |
Axogen, Inc. |
Common Stock, $0.01 par value |
10.51% |
$75M |
|
4.63M |
|
First Light Asset Management, LLC |
Dec 31, 2024 |
| KRMD |
KORU Medical Systems, Inc. |
Common Stock, $0.01 par value |
10.46% |
$12.3M |
$640K |
4.82M |
+5.51% |
Mathew P. Arens |
Apr 30, 2025 |
| ANAB |
ANAPTYSBIO, INC |
Common Stock, $0.01 par value |
7.71% |
$45.4M |
-$47.8M |
2.27M |
-51.3% |
Mathew P. Arens |
Jul 31, 2025 |
| NEO |
Neogenomics, Inc. |
Common Stock, $0.01 par value |
7.57% |
$65.6M |
|
9.78M |
|
Mathew P. Arens |
Jun 30, 2025 |
| ORGO |
Organogenesis Holdings, Inc. |
Common Stock, $0.01 par value |
6.55% |
$40.6M |
|
8.31M |
|
Mathew P. Arens |
Jun 30, 2025 |
| FNA |
Paragon 28, Inc. |
Common Stock, $0.01 par value |
1.7% |
$18.7M |
-$120M |
1.43M |
-86.5% |
Mathew P. Arens |
Feb 28, 2025 |
| OPRX |
OptimizeRx Corporation |
Common Stock, $0.01 par value |
0% |
$0 |
|
0 |
|
First Light Asset Management, LLC |
Dec 31, 2024 |